Literature DB >> 2707278

Relationships between essential fatty acid levels, pulmonary function and fat absorption in pre-adolescent cystic fibrosis children with good clinical scores.

G N Thompson1.   

Abstract

Twenty-one pre-adolescent cystic fibrosis (CF) children with good clinical scores had significant (P less than 0.001) deficiencies of arachidonic (mean 3.8% of total plasma fatty acids +/- SD 1.4) and linoleic (18.1 +/- 6.3) acids compared with controls (6.0 +/- 1.0, and 27.6 +/- 3.9, respectively). Despite the presence of pulmonary involvement of varying severity in all the CF children, neither arachidonic nor linoleic acid levels correlated significantly with pulmonary function measured by spirometry. All children had adequate caloric and fat intakes, and the coefficient of fat absorption correlated with none of the deficient fatty acid levels. These findings suggest that deficiencies of arachidonic and linoleic acids are of minor importance in the early development of pulmonary involvement in CF, and that factors other than fat malabsorption and decreased dietary intake probably contribute to fatty acid deficiency.

Entities:  

Mesh:

Substances:

Year:  1989        PMID: 2707278     DOI: 10.1007/BF00444126

Source DB:  PubMed          Journal:  Eur J Pediatr        ISSN: 0340-6199            Impact factor:   3.183


  24 in total

1.  A RESPIRATORY DISEASE SYNDROME IN CHICKENS FED ESSENTIAL FATTY ACID DEFICIENT DIETS.

Authors:  D T HOPKINS; R L WITTER; M C NESHEIM
Journal:  Proc Soc Exp Biol Med       Date:  1963-10

2.  Intravenous linoleic acid supplementation in children with cystic fibrosis.

Authors:  H P Chase; E K Cotton; R B Elliott
Journal:  Pediatrics       Date:  1979-08       Impact factor: 7.124

3.  Essential fatty acids in cystic fibrosis.

Authors:  M L Rosenlund; H K Kim; D Kritchevsky
Journal:  Nature       Date:  1974-10-25       Impact factor: 49.962

4.  The effect of medium chain triglyceride upon fat absorption and plasma lipid and depot fat of children with cystic fibrosis of the pancreas.

Authors:  P T Kuo; N N Huang
Journal:  J Clin Invest       Date:  1965-11       Impact factor: 14.808

5.  Long chain non-esterified fatty acid pattern in plasma of cystic fibrosis patients and their parents.

Authors:  V Rogiers; I Dab; R Crokaert; H L Vis
Journal:  Pediatr Res       Date:  1980-09       Impact factor: 3.756

6.  Essential fatty acid status in cystic fibrosis and the effects of safflower oil supplementation.

Authors:  J D Lloyd-Still; S B Johnson; R T Holman
Journal:  Am J Clin Nutr       Date:  1981-01       Impact factor: 7.045

7.  Abnormal pancreatic electrolyte secretion in cystic fibrosis. Reliability as a diagnostic marker.

Authors:  G P Davidson; C P Kirubakaran; G Ratcliffe; D M Cooper; T A Robb
Journal:  Acta Paediatr Scand       Date:  1986-01

8.  Correction of linoleic acid deficiency in cystic fibrosis.

Authors:  E H Mischler; S W Parrell; P M Farrell; W J Raynor; R J Lemen
Journal:  Pediatr Res       Date:  1986-01       Impact factor: 3.756

9.  Relationships between pulmonary function and plasma fatty acid levels in cystic fibrosis patients.

Authors:  R A Gibson; J K Teubner; K Haines; D M Cooper; G P Davidson
Journal:  J Pediatr Gastroenterol Nutr       Date:  1986 May-Jun       Impact factor: 2.839

10.  Improved growth and clinical, nutritional, and respiratory changes in response to nutritional therapy in cystic fibrosis.

Authors:  R Shepherd; W G Cooksley; W D Cooke
Journal:  J Pediatr       Date:  1980-09       Impact factor: 4.406

View more
  5 in total

1.  Low linoleic and high docosahexaenoic acids in a severe phenotype of transgenic cystic fibrosis mice.

Authors:  Birgitta Strandvik; Wanda K O Neal; Mohamed A Ali; Ulf Hammar
Journal:  Exp Biol Med (Maywood)       Date:  2018-03

2.  Serum linoleic acid status as a clinical indicator of essential fatty acid status in children with cystic fibrosis.

Authors:  Asim Maqbool; Joan I Schall; J Felipe Garcia-Espana; Babette S Zemel; Birgitta Strandvik; Virginia A Stallings
Journal:  J Pediatr Gastroenterol Nutr       Date:  2008-11       Impact factor: 2.839

3.  A mechanism accounting for the low cellular level of linoleic acid in cystic fibrosis and its reversal by DHA.

Authors:  M Rabie Al-Turkmani; Charlotte Andersson; Ragheed Alturkmani; Waddah Katrangi; Joanne E Cluette-Brown; Steven D Freedman; Michael Laposata
Journal:  J Lipid Res       Date:  2008-05-14       Impact factor: 5.922

4.  Mechanisms of lipid malabsorption in Cystic Fibrosis: the impact of essential fatty acids deficiency.

Authors:  N Peretti; V Marcil; E Drouin; E Levy
Journal:  Nutr Metab (Lond)       Date:  2005-05-03       Impact factor: 4.169

Review 5.  Abnormal unsaturated fatty acid metabolism in cystic fibrosis: biochemical mechanisms and clinical implications.

Authors:  Adam C Seegmiller
Journal:  Int J Mol Sci       Date:  2014-09-11       Impact factor: 5.923

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.